| Antigen: |
Vascular Endothelial Growth Factor (VEGF) |
| Relevance: |
VEGF is an angiogenic growth factor (i.e. it promotes the formation of new blood vessels). VEGF in serum is a prognostic indicator for cancer. |
| Clone: |
VG76e |
| Subclass: |
IgG1 murine |
| Applications: |
Western
ELISA |
| Immunogen: |
Human VEGF189 expressed
in E. coli |
| Reactivity: |
Human |
| Species raised in: |
Mouse, marmoset |
| Fusion partner: |
NS-1 |
| Recommended growth conditions: |
DMEM 10%FCS |
| References: |
Zhang L et al. 1998. J.
Path. 185:402-408  |
| Notes: |
Highly specific, but only weakly stains transfected cells (5-10%). Positive control: VEGF recombinant protein. 38-44 kDa MW. Reconises both native and denatured protein. |
For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com
Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information. |
